Cited by 482Pluripotent Stem Cells ResearchAlzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.

Modeling Alzheimer’s disease with iPSC-derived brain cells

Open access

Penney, Jay, Ralvenius, William T., Tsai, Li-Huei·2020·Molecular Psychiatry

DOI 10.1038/s41380-019-0468-3PMC PMC6906186

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed to benefit human patients. While hope remains that earlier intervention with existing therapeutics will improve outcomes, it is becoming increasingly clear that new approaches to understand and combat the pathophysiology of Alzheimer's disease are needed. Human induced pluripotent stem cell (iPSC) technologies have changed the face of preclinical research and iPSC-derived cell types are being utilized to study an array of human conditions, including neurodegenerative disease. All major brain cell types can now be differentiated from iPSCs, while increasingly complex co-culture systems are being developed to facilitate neuroscience research. Many cellular functions perturbed in Alzheimer's disease can be recapitulated using iPSC-derived cells in vitro, and co-culture platforms are beginning to yield insights into the complex interactions that occur between brain cell types during neurodegeneration. Further, iPSC-based systems and genome editing tools will be critical in understanding the roles of the numerous new genes and mutations found to modify Alzheimer's disease risk in the past decade. While still in their relative infancy, these developing iPSC-based technologies hold considerable promise to push forward efforts to combat Alzheimer's disease and other neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0468-3

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Brain cell types in Alzheimer’s disease. A summary of the major human brain cell types and the alterations they exhibit in ADCC BY · PubMed Central

Fig. 2 Human iPSC differentiation to brain cell types. Somatic cells from patients or healthy individuals can be reprogrammed to iPSCs and subsequently differentiated into all major brain cell types for in vitro studies. Such studies can examine cellular functions as well as how they are impacted by AD hallmark pathologies or AD-linked mutations. Genome editing techniques can be used to introduce or correct AD-linked mutations to examine phenotypes in isogenic backgrounds. 3D and co-culture models allow for examination of interactions occurring between cell types and sub-types to better model processes occurring in vivo. These and developing techniques hold promise for better understanding the relevant pathomechanisms underlying AD, and will hopefully facilitate development of effective therapeutics to combat dementiaCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017

Show all 235 references

Sorted by citations

Items 401–482 of 482

Additional file 1 of Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
Bai, B., Vanderwall, D., Li, Y., Wang, X., Poudel, S., Wang, H., Dey, K. K., Chen, P., Yang, K., & Peng, J. (2021) · Figshare · doi:10.6084/m9.figshare.15162179
Additional file 2 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151166
Additional file 4 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151172
Additional file 3 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151169
Can Stem Cell Therapy be an Effective Therapeutic Option for Complex and Neurological Conditions?
Lo, S., & Gantioque, R. (2024) · Advanced Journal of Graduate Research · doi:10.21467/ajgr.15.1.12-21
A Comprehensive Review of n-butylidenephthalide: The Potential Therapeutic Effect and Possibility for Targeted Therapy
Swati, Sarma, K., Bhardwaj, R., Chauhan, L., Sharma, R., & Mal, P. (2024) · The Natural Products Journal · doi:10.2174/0122103155287645240528114302
Prospects of induced pluripotent stem cells in treating advancing Alzheimer's disease: A review.
Park, J. J., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2025) · PubMed · doi:10.14670/hh-18-766
Relación entre el Uso de Toxinas Derivadas de Venenos de Animales Aplicadas a Moléculas para Tratamiento de Alzheimer
Espinosa, M. C. (2024) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v4i2.247
A human neuronal model of sporadic Alzheimer’s disease induced by FBXO2 downregulation shows Aβ aggregation, tau hyperphosphorylation and functional network impairmentPreprint
Díaz, A. G., Possenti, A., Urrutia, G. A., Bian, Y., Kedia, S., Böken, D., Lim, C. M., Licastro, D., Mannini, B., Klenerman, D., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.01.610673
Enfermedad de Alzheimer: reporte de caso
Saquinaula, R. B. M., Portilla, R. V. S., & Rivas, R. J. M. (2024) · Anatomía Digital · doi:10.33262/anatomiadigital.v7i3.3.3182
Merging iPSCs and “omics”: Advances in the field and potential applications to untangle neurodegenerative diseases
Streubel-Gallasch, L., & Seibler, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13550-7.00011-2
Phytotherapeutics for Alzheimer’s Disease
Kılıç, F. M. (2024) · doi:10.69860/nobel.9786053359241.7
Use of CRISPR system in genetic screening to detect neurodegenerative disease
Kar, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23826-0.00009-x
Automated medical diagnosis of dementia through fine-tuned EfficientNet
Bansal, D., Chhikara, R. R., Khanna, K., Dua, R. K., & Malhotra, R. (2024) · Intelligent Decision Technologies · doi:10.3233/idt-240988
Label-Free Multispectral Fluorescence Lifetime Imaging of Cerebral Organoids for Non-Invasive Alzheimer's Disease DiagnosisPreprint
Son, B., Han, J., Han, D., Kwon, S.-Y., Jeong, A., Kang, J. H., Yoo, K. H., Yoo, H., Gweon, B., & Park, H. H. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5165728
Advancements in Understanding Neurogenesis in Alzheimer's Disease: Current Research and Insights
Zhu, C. (2025) · Brain Conflux · doi:10.71321/4gjht115
Human iPSC-RPE with the PSEN1H163R pathogenic variant recapitulates Alzheimer’s disease features and reveals melanosome defectsPreprint
Lidgerwood, G. E., Mirzaei, M., Hall, J. C., Hernández, D. G., Greferath, U., van de Meene, A., Jessica, Y. W., Karch, C. M. M., Goate, A., & Pébay, A. (2025) · Research Square · doi:10.21203/rs.3.rs-6556064/v1
Disrupted structural connectivity-gray matter covariance coupling and associated cytoarchitectural and transcriptomic profiles in attention-deficit/hyperactivity disorder
Long, Y., Pan, N., Wang, S., Qin, K., Chen, Q., Vetter, C. S., Singh, M. K., Fornito, A., Chen, Y., & Gong, Q. (2025) · NeuroImage · doi:10.1016/j.neuroimage.2025.121402
Behavioral phenotypes in Alzheimer’s disease: exploring novel therapeutic targets using animal models and behavioral assays
Allahyani, W., Alrekabi, A., Almoqhem, R., Alyousef, A., Alasmari, F. F., Albaker, A. B., Al-Qerem, W. A., & Albasher, G. I. (2023) · Neurophysiology · doi:10.1007/s11062-025-09956-y
A 3D Human Neuron‐on‐Chip Platform to Monitor Neuronal Injury Responses
Tang, R., Latchoumane, C.-F. V., Chopra, A., Sarkar, M. M., Kim, C., Gonsalves, N., Wu, H., Sentmanat, J. C., Liu, A., Mhatre‐Winters, I., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.202503457
P06-08 Investigation of the Effects of Naringin in an In vitroAlzheimer's Disease Model
Korkmaz, E., Secerlı, J., Erdoğan, H., & Bacanli, M. G. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.07.246
How Human Induced Pluripotent Stem Cells‐Derived Models can Advance our Understanding of Secretion Mechanisms in Physiological and Pathological Contexts?
Fourrière, L., & Boncompain, G. (2025) · Biology of the Cell · doi:10.1111/boc.70035
Whole Exome Sequencing Reveals Novel Genetic Mutations in the ADAM10 Underlying Familial Alzheimer’s Disease
Ullah, A., & Iftikhar, S. (2025) · Current Genetic Medicine Reports · doi:10.1007/s40142-025-00220-7
3D Bioprinting Neural Models: A New Era in Drug Discovery and Neuropharmacology
Karad, V., Patil, P. P. R. P. P. P. R., & Gupta, G. L. (2025) · Biomedical Materials & Devices · doi:10.1007/s44174-025-00530-y
Modeling Alzheimer’s Disease with APOE4 Neuron-Glial Brain Assembloids Reveals IGFBPs as Therapeutic TargetsPreprint
Sherman, E., Qiu, K., Roberts, R., Shichman, L., Li, S., Sun, H., Ide, L., Tucker, A., Lee, S., Gniadzik, W., et al. (2025) · SSRN Electronic Journal · doi:10.1101/2025.10.17.683162 · Cited by 1
Investigation of Neurons and Microglia from APOE3 Induced Pluripotent Stem Cells using Data-Independent Acquisitions on a ZenoTOF 7600Preprint
Burton, J. B., McHugh, T. L. M., Schurman, C. A., Bons, J., Sanchez, M., Ellerby, L., & Schilling, B. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.02.686128
iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer’s disease immunotherapy
Chinnathambi, S., Adityan, A., Chandrashekar, M., & Velmurugan, G. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.001 · Cited by 1
Additional file 2 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.25237419
Additional file 8 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151190
Additional file 1 of Intracellular deposits of amyloid-beta influence the ability of human iPSC-derived astrocytes to support neuronal function
Konstantinidis, E., Portal, B., Mothes, T., Beretta, C., Lindskog, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22603982
Additional file 6 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681788
Stem cell innovation in neurological and neurodegenerative disorders: general conclusion, challenges, and prospective
Hashash, A. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27414-5.00009-9
Additional file 9 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151193
Additional file 1 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151163
Additional file 1 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.25237386
Additional file 7 of Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24151187
Additional file 5 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681785
Additional file 7 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681791
Additional file 3 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681779
Additional file 4 of Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Cuní‐López, C., Stewart, R., Oikari, L. E., Nguyen, T. H., Roberts, T. L., Sun, Y., Guo, C. C., Lupton, M. K., White, A. R., & Quek, H. (2024) · Figshare · doi:10.6084/m9.figshare.26681782
A Microglia Initiated Target Therapy in Neuroinflammation for Alzheimer’s Patients
Faiza, B. K., Abedi, A., Andrea, O. B. O., Tamar, G., & Chermahini, S. H. (2024) · Journal of Alzheimers Research and Therapy · doi:10.14302/issn.2998-4211.jalr-24-4926
Microarray analysis for transcriptomic profiling in neuroscience: uncovering key molecular mechanisms and candidate biomarkers in Alzheimer’s disease
Jalilvand, A. (2026) · 3 Biotech · doi:10.1007/s13205-025-04645-3
Glial and Neuronal Alzheimer's Disease-Related Alterations Reproduced in Human Induced Pluripotent Stem Cells With Presenilin-1 MutationPreprint
Comolli, D., Murari, E., Cerovic, M., Soltuzu, L., Liao, W., Bianchi, A., Seminara, S., Craparotta, I., Fumagalli, S., Balducci, C., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8549806/v1
Protocol for the generation and xenotransplantation of human induced pluripotent stem cell-derived neural progenitor cells into the mouse forebrain
McInvale, J. J., Ayers, C. E., Sarmah, H., Kim, K., Reinhardt, P., Mahajan, A., Humala, N., Corneo, B., Sterneckert, J. L., Canoll, P., et al. (2026) · STAR Protocols · doi:10.1016/j.xpro.2025.104305
Analysis of intracellular organelles in neurons differentiated from iPSCs of Chédiak‐Higashi syndrome patients
Nakamura, Y., Ito, M., Senoo, A., Oh, S., Niwa, A., Hashimoto, Y., Hagiwara, H., Uemura, Y., Tsuji, T., Ohnishi, H., et al. (2026) · Pediatrics International · doi:10.1111/ped.70326
Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer’s diseasePreprint
Graß, T., Cosacak, I. M., Ordureau, A., Price, F. D., Kavali, S., Caldarelli, A., Qiao, M. N., Vardarajan, B. N., Paulo, J. A., Marass, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.19.706886 · Cited by 1
SGK1 inhibition restores excitability of cortical neurons derived from Alzheimer's disease patients
Jiang, Z., Saleem, K., Fisher, E., Li, L., Yan, Z., & Feng, J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107345
Label-free multispectral fluorescence lifetime imaging enables non-invasive diagnosis of Alzheimer’s disease in cerebral organoids
Son, B., Han, J., Kang, J., Jeong, I., Han, D., Kwon, S., Jung, A., Yoo, H., Gweon, B., & Park, H. H. (2026) · Nano Today · doi:10.1016/j.nantod.2026.103020
A calcium imaging pipeline to detect and quantify compound-specific effects in human and mouse astrocytes and astrocyte-neuron coculturesPreprint
Krohn, J., Breuer, L., Wegmann, S., & Dean, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.19.712916
From mice to clinical relevance: humanizing neuroscience with human-based model systems
Bak, A., van Loo, K. M. J., Kronenberg‐Versteeg, D., & Koch, H. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1776439
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
Implication de nouvelles cibles microgliales, Cst7 et Clec7a/Dectin-1, dans le développement et la progression de la maladie d'Alzheimer
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Étude des perturbations astrocytaires sous l’influence de l’apolipoprotéine E4 : implications et applications dans la maladie d’Alzheimer
Arnaud, L. (2021) · theses.fr (ABES) · doi:10.70675/11e3cc48zf040z4b8azb1d3zb7f6a6eed96b
Alzheimer’s disease : epistemology, ethics, innovation
Daly, T. P. (2021) · theses.fr (ABES) · doi:10.70675/6e99838az7dd4z402fz98fdzeca072d3ad13
The role of the α7 nicotinic acetylcholine receptor in a model of amyloid pathology
Santos, D. G. (2024) · theses.fr (ABES) · doi:10.70675/b3ed4de5zcd9ez4421za129z0a05130d86b9
Patient-Derived Brain Organoids as Translational Platforms for Regenerating the Degenerating Brain: Bridging Bench Models to Clinical Therapies
Debasrita, B. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014630
Rejuvenating stem cells to reverse aging
Ranwa, S., Yadav, S., Nurboo, S., & Nazir, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33159-6.00019-9
Multiomic Profiling of 85 iPSC Lines from Familial Dementia Reveals Cellular Diversity and Regulators of Organoid DevelopmentPreprint
Qi, L., Bertucci, T. B., Borden, S. M., Arduini, B. L., Lotz, S., Bowles, K. R., Goate, A., Karch, C. M. M., Temple, S., & Geschwind, D. H. (2026) · SSRN Electronic Journal · doi:10.64898/2026.04.29.721747
Investigating the Role of Inositol 1,4,5-Trisphosphate Receptors in the Pathogenesis of Alzheimer’s Disease Through Computational Modeling
Akter, S., Ullah, G., & Ullah, A. (2026) · Biophysica · doi:10.3390/biophysica6030042
WWOX in brain development and disease: Molecular mechanisms and therapeutic opportunities
Obeid, M., Wang, J., Abudiab, B., Akkawi, R., & Aqeilan, R. I. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107446 · Cited by 1
Rapid generation of human sensory neurons from iPSC for modeling of peripheral neuropathies
James, M. E., Chan, S. S. P., HU, B., & Farah, M. H. (2026) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2026.110837
NeuroEnergetics-on-Chip: a novel 3-compartment microfluidic platform to study metabolic interactions between brain parenchyma and cerebral vasculaturePreprint
Torres, A. P. C., Montesi, L., Loel, L., Yanovska, M., Venckute, J., Jessika, J., Wu, T., Benito‐Zarza, L., Cognetti, J. S., Fotouhi, O., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.21.733618
Advances in 3D cell culture models for Alzheimer’s Disease drug discovery
Valdivia-Aviña, K., Ochoa-Hugo, S. E., Hernández-Sapiéns, M. A., & Canales-Aguirre, A. A. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2691833
Rapid and efficient oligodendrocyte differentiation from human pluripotent stem cells via dual inhibition of BMP and Notch signalingPreprint
Evangelisti, A., Phillips, S. M., Jungverdorben, J., Walsh, R. M., Wu, Y., Bocchi, V. D., Zhou, T., & Studer, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.30.729930
Deep Learning for Alzheimer’s Disease Classification: A Systematic Review of Algorithmic Effectiveness
Basha, S. K., & Khasim, S. (2026) · Lecture notes in networks and systems · doi:10.1007/978-3-032-08600-6_22
In vitro and In vivo Pharmacological Screening Methods Available for Alzheimer’s Disease and Dementia
Jain, S., Kriti, K., & Acharya, R. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815523126010010
Generation of a human induced pluripotent stem cell line (HEBHMUi019-A) from a 67-year-old male Alzheimer’s patient with APOE-ε4/ε4 genotype
Ma, J., Hua, Z., Zhao, B., Xu, J., Bao, K., & Guo, R. (2026) · Stem Cell Research · doi:10.1016/j.scr.2026.104082
Integrative Transcriptomics and Mendelian Randomization Identify RGS1 as a Causal Immune Regulator in Alzheimer’s Disease
Cheng, Z., Bai, R., & Diao, Y. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080828
Quantum Augmented Multiomics Integration for Alzheimer Disease Drug Repurposing Using Variational Quantum Eignsolver Validation
Ashakin, M. R., Stuetzle, C. S., Haider, M. R., Khan, R. I., & Roosan, D. (2026) · Computational and Structural Biotechnology Reports · doi:10.34133/csbr.0010
AMBMP Hydrochloride Reverses STZ-Induced Alzheimer-Type Dementia Associated with Wnt/β-catenin/TLR4 Signaling
Kalra, P., Chaturvedi, D., Kumar, A., Grewal, A. K., Khan, H., Singh, V., Singh, T. G., Singh, T., Ahmad, S. F., & Attia, S. M. (2026) · NeuroMolecular Medicine · doi:10.1007/s12017-026-08947-4
Advances in hiPSC-Based Models of Complex Neurological Disorders
Giadone, R. M., Sartore, R., Arlotta, P., & Rubin, L. L. (2026) · Springer eBooks · doi:10.1007/978-3-032-31497-0_10
APOE 4/4 promotes dysfunctional and inflammatory phenotypes concomitant with impaired maturation of hiPSC-derived astrocytesPreprint
Vecino, R., Díaz‐Guerra, E., Arribas-González, E., Gil, D. S., Acosta, F. J. F., Serra, I., Moreno‐Jiménez, E. P., Moratalla, R., Navarrete, M., & Vicario‐Abejón, C. (2026) · Research Square · doi:10.21203/rs.3.rs-10968101/v1
Minor Phytocannabinoids as Candidate Multi-Target Modulators of Endoplasmic Reticulum Stress-Linked Proteostasis Failure in Alzheimer’s Disease: A Mechanistic Review
이혜원, Park, S., & Chae, H. (2026) · Biomolecules · doi:10.3390/biom16101383
APOE4 differentially alters lipid composition in extracellular vesicles from hiPSC-derived neurons of Alzheimer’s disease patients
Krokidis, M. G., Sagar, R., Mustapić, M., Papatheodorou, M.-C. P., Exarchos, T. P., Lyketsos, C. G., Vlamos, P., Kapogiannis, D., & Mahairaki, V. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1917428
From Amyloid Exposure to Genetic Causality: Converging hiPSC-Based Models of Alzheimer’s Disease
Colasuonno, F., Valenza, A., Rossin, F., & Moreno, S. (2026) · Cells · doi:10.3390/cells15191793
From patient cells to patient therapy: Twenty years of iPSC-based translation in neurodegenerative disease
Cha, Y., & Kim, K. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.103104
Structural and metabolic reprogramming by docosahexaenoic acid in neuronal cell models of Alzheimer’s disease
Rana, A., Plourde, M., Van, A. L., & Bernoud‐Hubac, N. (2026) · Biochimie · doi:10.1016/j.biochi.2026.10.005
Engineered peroxisomes and patient-derived iPSC models as potential biomaterial platforms for precision neuroprotection in oxidative stress-driven central nervous system disorders
Matta, C., Cheon, Y.-H., Vágó, J., Mészár, Z., Kim, E. H., Jiang, S., Balogh, A., Zana, M., Dinnyés, A., & Jin, E. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103752
Multi-omic profiling of 85 iPSC lines from familial dementia reveals cellular diversity and regulators of organoid development
Qi, L., Bertucci, T. B., Borden, S. M., Arduini, B. L., Lotz, S., Bowles, K. R., Goate, A., Karch, C. M. M., Temple, S., & Geschwind, D. H. (2026) · Neuron · doi:10.1016/j.neuron.2026.09.022
Programming brain endothelial identity: Transcription factor and genome engineering approaches to improve iPSC-derived BBB models
Hwang, R. W., Li, Y. B., Marcotte, R., Costain, W., & Jezierski, A. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103116
Deanna Protocol Ameliorates the Deficits in Human iPSC ‐Cortical Neurons Carrying Familial Alzheimer's Mutation
Soares, L. K., Srivastava, G. K., Dwelle, C., Waggoner, B., Tedone, V., Hickman, J. J., & Guo, X. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71205
Engineering human brain microphysiological systems for alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE) modeling and drug testing: translational promise, limitations, and future directions
Yun, Y., Jena, S., Egido-Betancourt, H., Uzoechi, S., Kim, D. Y., Lee, J.-M., & Nguyen, J. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115982

Authors: Penney, J., Ralvenius, W. T., & Tsai, L.-H.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Tsai, Li-Huei
ORCID: Penney, Jay
Ralvenius, William T.
Tsai, Li-Huei
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2019-08-07
Volume: 25
Issue: 1
Pages: 148-167
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/s41380-019-0468-3
PMC: PMC6906186
OpenAlex: W2964627277
Cited by: 471
References: 235
Citations by year: 2026: 54 · 2025: 66 · 2024: 78 · 2023: 84 · 2022: 77 · 2021: 65 · 2020: 41 · 2019: 6
FWCI: 4.18
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Molecular Psychiatry (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
IslandScholar (University of Prince Edward Island) (submittedVersion)
Funders: National Science Foundation
Cure Alzheimer's Fund
Robert A. and Renee E. Belfer Family Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177920)
National Institutes of Health (NS051874)
National Institute on Aging (RF1AG054012)
National Institute of Neurological Disorders and Stroke (R37NS051874)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: Alzheimer's disease, induced pluripotent stem cells, neurodegeneration, co-culture model, disease modeling, genome editing, Alzheimer's disease risk genes, preclinical research
MeSH terms: Alzheimer Disease, Brain, Cell Differentiation, Humans, Models, Biological, Neurons, Neurodegenerative Diseases, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modeling Alzheimer’s disease with iPSC-derived brain cells

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks